Research & Development
20 January 2022 - Danish biotechnology company Zealand Pharma A/S (NASDAQ:ZEAL) (CPH:ZEAL) has completed patient enrolment in its pivotal Phase 3 trial (EASE-SBS 1) of glepaglutide, the company announ...
19 January 2022 - - US-based Omeros Corp. (NASDAQ: OMER) has confirmed that earlier this month the company submitted to the US Food and Drug Administration its response to the Agency's Complete R...
19 January 2022 - - The United States Food and Drug Administration approved Cibinqo (abrocitinib), an oral, once-daily, Janus kinase 1 inhibitor, for the treatment of adults living with refractory, mo...
19 January 2022 - - US-based pharmaceutical company Merck (NYSE: MRK) and US-based biotechnology company Ridgeback Biotherapeutics have signed a long-term supply agreement with the United Nations Chil...
19 January 2022 - - US-based biotech innovation company Aditxt, Inc (NASDAQ: ADTX) has submitted two EUA applications for AditxtScore for COVID-19, the company said.

The company said this...
19 January 2022 - Swedish immuno-oncology company BioInvent International AB (STO:BINV) announced on Wednesday that it has received Orphan Drug Designation (ODD) in the United States for its anti-FcyR...
Related Headlines